These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
197 related items for PubMed ID: 16140302
1. Analysis of immune response patterns in naïve and Plasmodium berghei-infected young rats following a ferroquine treatment. Pierrot C, Lafitte S, Dive D, Fraisse L, Brocard J, Khalife J. Int J Parasitol; 2005 Dec; 35(14):1601-10. PubMed ID: 16140302 [Abstract] [Full Text] [Related]
3. The effect of chloroquine on the production of interferon-gamma, interleukin (IL)-4, IL-6, and IL-10 in Plasmodium chabaudi chabaudi in infected C57BL6 mice. Rosa R, Silveira H, Seixas E, Rolão N, Santos-Gomes G, do Rosário V. J Parasitol; 1999 Oct; 85(5):956-60. PubMed ID: 10577734 [Abstract] [Full Text] [Related]
5. Chloroquine efficacy in Plasmodium berghei NK65-infected ICR mice, with reference to the influence of initial parasite load and starting day of drug administration on the outcome of treatment. Ishih A, Suzuki T, Muregi FW, Matsui K, Terada M. Southeast Asian J Trop Med Public Health; 2006 Jan; 37(1):13-7. PubMed ID: 16771206 [Abstract] [Full Text] [Related]
6. Insights into the mechanism of action of ferroquine. Relationship between physicochemical properties and antiplasmodial activity. Biot C, Taramelli D, Forfar-Bares I, Maciejewski LA, Boyce M, Nowogrocki G, Brocard JS, Basilico N, Olliaro P, Egan TJ. Mol Pharm; 2005 Jan; 2(3):185-93. PubMed ID: 15934779 [Abstract] [Full Text] [Related]
7. Plasmodium berghei: dehydroepiandrosterone sulfate reverses chloroquino-resistance in experimental malaria infection; correlation with glucose 6-phosphate dehydrogenase and glutathione synthesis pathway. Safeukui I, Mangou F, Malvy D, Vincendeau P, Mossalayi D, Haumont G, Vatan R, Olliaro P, Millet P. Biochem Pharmacol; 2004 Nov 15; 68(10):1903-10. PubMed ID: 15476661 [Abstract] [Full Text] [Related]
8. Parasitological and clinical efficacy of standard treatment regimens against Plasmodium falciparum, P. vivax and P. malariae in Papua New Guinea. Genton B, Baea K, Lorry K, Ginny M, Wines B, Alpers MP. P N G Med J; 2005 Nov 15; 48(3-4):141-50. PubMed ID: 17212060 [Abstract] [Full Text] [Related]
9. Rifampicin antagonizes the effect of choloroquine on chloroquine-resistant Plasmodium berghei in mice. Hou LJ, Raju SS, Abdulah MS, Nor NM, Ravichandran M. Jpn J Infect Dis; 2004 Oct 15; 57(5):198-202. PubMed ID: 15507775 [Abstract] [Full Text] [Related]
10. Inhibitory activity of ferroquine, versus chloroquine, against western Kenya Plasmodium falciparum field isolates determined by a SYBR Green I in vitro assay. Eyase FL, Akala HM, Johnson JD, Walsh DS. Am J Trop Med Hyg; 2011 Dec 15; 85(6):984-8. PubMed ID: 22144431 [Abstract] [Full Text] [Related]
11. Antagonism of serum of mice infected with chloroquine-resistant 'NS' line to the antimalarial action of chloroquine. Li GD, Qian YL, Chen L. Zhongguo Yao Li Xue Bao; 1989 May 15; 10(3):257-60. PubMed ID: 2692400 [Abstract] [Full Text] [Related]
12. Supplementation of CXCL12 (CXCL12) induces homing of CD11c+ dendritic cells to the spleen and enhances control of Plasmodium berghei malaria in BALB/c mice. Garnica MR, de Moraes LV, Rizzo LV, de Andrade HF. Immunology; 2005 Jul 15; 115(3):399-406. PubMed ID: 15946257 [Abstract] [Full Text] [Related]
13. Possible involvement of IFN-gamma in early mortality of Plasmodium berghei NK65-infected BALB/c mice after febrifugine treatment. Ishih A, Nagata T, Kobayashi F, Muregi FW, Ohori K, Miyase T. Southeast Asian J Trop Med Public Health; 2008 Nov 15; 39(6):949-58. PubMed ID: 19062681 [Abstract] [Full Text] [Related]
14. Opening up the advantages of the ruthenocenic bioprobes of ferroquine: distribution and localization in Plasmodium falciparum-infected erythrocytes. Biot C, Dubar F, Khalife J, Slomianny C. Metallomics; 2012 Aug 15; 4(8):780-3. PubMed ID: 22700030 [Abstract] [Full Text] [Related]
15. Plasmodium yoelii: influence of antimalarial treatment on acquisition of immunity in BALB/c and DBA/2 mice. Ma SH, Zheng L, Liu YJ, Guo SY, Feng H, Chen G, Li DM, Wang JC, Cao YM. Exp Parasitol; 2007 Jul 15; 116(3):266-72. PubMed ID: 17336298 [Abstract] [Full Text] [Related]
16. [Accumulation and effluxion of chloroquine in chloroquine-sensitive and chloroquine-resistant Plasmodium berghei]. Wang Q, Wang M, Chang H, Yang B. Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 1998 Jul 15; 16(3):189-92. PubMed ID: 12078239 [Abstract] [Full Text] [Related]
17. In Vivo antimalarial activity of aqueous extracts from Kenyan medicinal plants and their chloroquine (CQ) potentiation effects against a blood-induced CQ-resistant rodent parasite in mice. Muregi FW, Ishih A, Suzuki T, Kino H, Amano T, Mkoji GM, Miyase T, Terada M. Phytother Res; 2007 Apr 15; 21(4):337-43. PubMed ID: 17221829 [Abstract] [Full Text] [Related]
18. 16alpha-bromoepiandrosterone, a dehydroepiandrosterone (DHEA) analogue, inhibits Plasmodium falciparum and Plasmodium berghei growth. Freilich D, Ferris S, Wallace M, Leach L, Kallen A, Frincke J, Ahlem C, Hacker M, Nelson D, Hebert J. Am J Trop Med Hyg; 2000 Apr 15; 63(5-6):280-3. PubMed ID: 11421378 [Abstract] [Full Text] [Related]
19. In vitro metabolism of ferroquine (SSR97193) in animal and human hepatic models and antimalarial activity of major metabolites on Plasmodium falciparum. Daher W, Pelinski L, Klieber S, Sadoun F, Meunier V, Bourrié M, Biot C, Guillou F, Fabre G, Brocard J, Fraisse L, Maffrand JP, Khalife J, Dive D. Drug Metab Dispos; 2006 Apr 15; 34(4):667-82. PubMed ID: 16415117 [Abstract] [Full Text] [Related]
20. In vitro activity of ferroquine (SAR97193) is independent of chloroquine resistance in Plasmodium falciparum. Kreidenweiss A, Kremsner PG, Dietz K, Mordmüller B. Am J Trop Med Hyg; 2006 Dec 15; 75(6):1178-81. PubMed ID: 17172389 [Abstract] [Full Text] [Related] Page: [Next] [New Search]